Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06683716

SmartGlass-Guided ERCP with Cannulation of Native Papilla 1.0

Remote Assistance Via Smart Glasses Compared to In-person Assistance for Cannulation of the Native Papilla During Endoscopic Retrograde Cholangiopancreatography

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Helios Kliniken Schwerin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this prospective randomized study is to evaluate whether telemedical assistance via SmartGlasses is equivalent to physical presence in teaching Endoscopic Retrograde Cholangiopancreaticography (ERCP) in terms of examination success and safety. Endoscopic papilla cannulation is a key skill for successful ERCP and therefore a measurable primary endpoint of the study. This can be measured as the time (in seconds/minutes) between stable visualization of the papilla and successful endoscopic cannulation of the target structure (bile duct or pancreatic duct).

Detailed description

In sparsely populated regions of a country and where there is a lack of experienced specialists, it may not always be possible to have an experienced ERCP examiner present during an examination. Therefore, telemedical examination assistance via a connection to data glasses worn by the examiner is a possible option to replace the physical presence of an instructor or experienced ERCP examiner. The aim of this prospective randomized study is to evaluate whether telemedical assistance via smart glasses is equivalent to physical presence in terms of examination success and safety. Endoscopic papilla cannulation is a key skill for successful ERCP and therefore a measurable primary endpoint of the study. This can be measured as the time (in seconds/minutes) between stable visualization of the papilla and successful endoscopic cannulation of the target structure (bile duct or pancreatic duct). In addition to other efficacy endpoints, adverse events, which are expected to be rare, will be documented at 48-hour intervals and calculated as a rate. Telemedical 'live' support of an ERCP via data glasses has not yet been demonstrated or tested in a trial. To ensure the safety of the examination under these circumstances, the training examiner is present in the neighbouring room and can physically assist or take over the examination at any time if necessary.

Conditions

Interventions

TypeNameDescription
OTHERTraining in presence of the instructorThe instructor gives the trainee instructions for the examination while he/she is present in the examination room.
OTHERTelemedically training by an instructorThe trainer gives instructions to the trainee through a telemedical connection to the examiner using SmartGlasses

Timeline

Start date
2025-01-02
Primary completion
2026-06-01
Completion
2026-12-31
First posted
2024-11-12
Last updated
2024-11-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06683716. Inclusion in this directory is not an endorsement.